Bharat Biotech to Develop Lifesaving Shigella Shot
June 12, 2025: Bharat Biotech to Advance Development of GSK’s Shigella Vaccine Candidate for Severe Bacterial Diarrhoea Hyderabad, India – 12 June 2025 – Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing, today announced that it has partnered with GSK plc (LSE/NYSE: GSK) for the ongoing development and potential use […]
Bharat Biotech to Develop Lifesaving Shigella Shot Read More »